The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Intravenous Sets-Global Market Insights and Sales Trends 2024
Synopsis
The global Intravenous Sets market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Intravenous Sets in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Intravenous Sets market. 10 gtts / ml, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 15 gtts / ml segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Intravenous Sets market, driven by demand from China, the second largest economy with some signs of stabilising, the Intravenous Sets market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intravenous Sets, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intravenous Sets market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intravenous Sets market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intravenous Sets sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intravenous Sets covered in this report include B. Braun, CareFusion, Fresenius Kabi, Codan, Hospira, Baxter International, Vygon, Smiths Medical and ICU Medical, etc.
The global Intravenous Sets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
B. Braun
CareFusion
Fresenius Kabi
Codan
Hospira
Baxter International
Vygon
Smiths Medical
ICU Medical
Cair
Rays Spa
Benefis Srl
Global Intravenous Sets market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intravenous Sets market, Segment by Type:
10 gtts / ml
15 gtts / ml
20 gtts / ml
Other
Global Intravenous Sets market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intravenous Sets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intravenous Sets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Intravenous Sets market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Intravenous Sets in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Intravenous Sets market. 10 gtts / ml, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 15 gtts / ml segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Intravenous Sets market, driven by demand from China, the second largest economy with some signs of stabilising, the Intravenous Sets market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intravenous Sets, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intravenous Sets market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intravenous Sets market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intravenous Sets sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intravenous Sets covered in this report include B. Braun, CareFusion, Fresenius Kabi, Codan, Hospira, Baxter International, Vygon, Smiths Medical and ICU Medical, etc.
The global Intravenous Sets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
B. Braun
CareFusion
Fresenius Kabi
Codan
Hospira
Baxter International
Vygon
Smiths Medical
ICU Medical
Cair
Rays Spa
Benefis Srl
Global Intravenous Sets market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intravenous Sets market, Segment by Type:
10 gtts / ml
15 gtts / ml
20 gtts / ml
Other
Global Intravenous Sets market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intravenous Sets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intravenous Sets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Intravenous Sets Market Overview
1.1 Intravenous Sets Product Overview
1.2 Intravenous Sets Market Segment by Type
1.2.1 10 gtts / ml
1.2.2 15 gtts / ml
1.2.3 20 gtts / ml
1.2.4 Other
1.3 Global Intravenous Sets Market Size by Type
1.3.1 Global Intravenous Sets Market Size Overview by Type (2018-2029)
1.3.2 Global Intravenous Sets Historic Market Size Review by Type (2018-2023)
1.3.3 Global Intravenous Sets Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Intravenous Sets Sales Breakdown by Type (2018-2023)
1.4.2 Europe Intravenous Sets Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Intravenous Sets Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Intravenous Sets Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Intravenous Sets Sales Breakdown by Type (2018-2023)
2 Global Intravenous Sets Market Competition by Company
2.1 Global Top Players by Intravenous Sets Sales (2018-2023)
2.2 Global Top Players by Intravenous Sets Revenue (2018-2023)
2.3 Global Top Players by Intravenous Sets Price (2018-2023)
2.4 Global Top Manufacturers Intravenous Sets Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intravenous Sets Market Competitive Situation and Trends
2.5.1 Intravenous Sets Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Intravenous Sets Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous Sets as of 2022)
2.7 Date of Key Manufacturers Enter into Intravenous Sets Market
2.8 Key Manufacturers Intravenous Sets Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intravenous Sets Status and Outlook by Region
3.1 Global Intravenous Sets Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Intravenous Sets Historic Market Size by Region
3.2.1 Global Intravenous Sets Sales in Volume by Region (2018-2023)
3.2.2 Global Intravenous Sets Sales in Value by Region (2018-2023)
3.2.3 Global Intravenous Sets Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Intravenous Sets Forecasted Market Size by Region
3.3.1 Global Intravenous Sets Sales in Volume by Region (2024-2029)
3.3.2 Global Intravenous Sets Sales in Value by Region (2024-2029)
3.3.3 Global Intravenous Sets Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Intravenous Sets by Application
4.1 Intravenous Sets Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Intravenous Sets Market Size by Application
4.2.1 Global Intravenous Sets Market Size Overview by Application (2018-2029)
4.2.2 Global Intravenous Sets Historic Market Size Review by Application (2018-2023)
4.2.3 Global Intravenous Sets Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Intravenous Sets Sales Breakdown by Application (2018-2023)
4.3.2 Europe Intravenous Sets Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Intravenous Sets Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Intravenous Sets Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Intravenous Sets Sales Breakdown by Application (2018-2023)
5 North America Intravenous Sets by Country
5.1 North America Intravenous Sets Historic Market Size by Country
5.1.1 North America Intravenous Sets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Intravenous Sets Sales in Volume by Country (2018-2023)
5.1.3 North America Intravenous Sets Sales in Value by Country (2018-2023)
5.2 North America Intravenous Sets Forecasted Market Size by Country
5.2.1 North America Intravenous Sets Sales in Volume by Country (2024-2029)
5.2.2 North America Intravenous Sets Sales in Value by Country (2024-2029)
6 Europe Intravenous Sets by Country
6.1 Europe Intravenous Sets Historic Market Size by Country
6.1.1 Europe Intravenous Sets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Intravenous Sets Sales in Volume by Country (2018-2023)
6.1.3 Europe Intravenous Sets Sales in Value by Country (2018-2023)
6.2 Europe Intravenous Sets Forecasted Market Size by Country
6.2.1 Europe Intravenous Sets Sales in Volume by Country (2024-2029)
6.2.2 Europe Intravenous Sets Sales in Value by Country (2024-2029)
7 Asia-Pacific Intravenous Sets by Region
7.1 Asia-Pacific Intravenous Sets Historic Market Size by Region
7.1.1 Asia-Pacific Intravenous Sets Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Intravenous Sets Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Intravenous Sets Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Intravenous Sets Forecasted Market Size by Region
7.2.1 Asia-Pacific Intravenous Sets Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Intravenous Sets Sales in Value by Region (2024-2029)
8 Latin America Intravenous Sets by Country
8.1 Latin America Intravenous Sets Historic Market Size by Country
8.1.1 Latin America Intravenous Sets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Intravenous Sets Sales in Volume by Country (2018-2023)
8.1.3 Latin America Intravenous Sets Sales in Value by Country (2018-2023)
8.2 Latin America Intravenous Sets Forecasted Market Size by Country
8.2.1 Latin America Intravenous Sets Sales in Volume by Country (2024-2029)
8.2.2 Latin America Intravenous Sets Sales in Value by Country (2024-2029)
9 Middle East and Africa Intravenous Sets by Country
9.1 Middle East and Africa Intravenous Sets Historic Market Size by Country
9.1.1 Middle East and Africa Intravenous Sets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Intravenous Sets Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Intravenous Sets Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Intravenous Sets Forecasted Market Size by Country
9.2.1 Middle East and Africa Intravenous Sets Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Intravenous Sets Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 B. Braun
10.1.1 B. Braun Company Information
10.1.2 B. Braun Introduction and Business Overview
10.1.3 B. Braun Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.1.4 B. Braun Intravenous Sets Products Offered
10.1.5 B. Braun Recent Development
10.2 CareFusion
10.2.1 CareFusion Company Information
10.2.2 CareFusion Introduction and Business Overview
10.2.3 CareFusion Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CareFusion Intravenous Sets Products Offered
10.2.5 CareFusion Recent Development
10.3 Fresenius Kabi
10.3.1 Fresenius Kabi Company Information
10.3.2 Fresenius Kabi Introduction and Business Overview
10.3.3 Fresenius Kabi Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Fresenius Kabi Intravenous Sets Products Offered
10.3.5 Fresenius Kabi Recent Development
10.4 Codan
10.4.1 Codan Company Information
10.4.2 Codan Introduction and Business Overview
10.4.3 Codan Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Codan Intravenous Sets Products Offered
10.4.5 Codan Recent Development
10.5 Hospira
10.5.1 Hospira Company Information
10.5.2 Hospira Introduction and Business Overview
10.5.3 Hospira Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hospira Intravenous Sets Products Offered
10.5.5 Hospira Recent Development
10.6 Baxter International
10.6.1 Baxter International Company Information
10.6.2 Baxter International Introduction and Business Overview
10.6.3 Baxter International Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Baxter International Intravenous Sets Products Offered
10.6.5 Baxter International Recent Development
10.7 Vygon
10.7.1 Vygon Company Information
10.7.2 Vygon Introduction and Business Overview
10.7.3 Vygon Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Vygon Intravenous Sets Products Offered
10.7.5 Vygon Recent Development
10.8 Smiths Medical
10.8.1 Smiths Medical Company Information
10.8.2 Smiths Medical Introduction and Business Overview
10.8.3 Smiths Medical Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Smiths Medical Intravenous Sets Products Offered
10.8.5 Smiths Medical Recent Development
10.9 ICU Medical
10.9.1 ICU Medical Company Information
10.9.2 ICU Medical Introduction and Business Overview
10.9.3 ICU Medical Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.9.4 ICU Medical Intravenous Sets Products Offered
10.9.5 ICU Medical Recent Development
10.10 Cair
10.10.1 Cair Company Information
10.10.2 Cair Introduction and Business Overview
10.10.3 Cair Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Cair Intravenous Sets Products Offered
10.10.5 Cair Recent Development
10.11 Rays Spa
10.11.1 Rays Spa Company Information
10.11.2 Rays Spa Introduction and Business Overview
10.11.3 Rays Spa Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Rays Spa Intravenous Sets Products Offered
10.11.5 Rays Spa Recent Development
10.12 Benefis Srl
10.12.1 Benefis Srl Company Information
10.12.2 Benefis Srl Introduction and Business Overview
10.12.3 Benefis Srl Intravenous Sets Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Benefis Srl Intravenous Sets Products Offered
10.12.5 Benefis Srl Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intravenous Sets Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intravenous Sets Industrial Chain Analysis
11.4 Intravenous Sets Market Dynamics
11.4.1 Intravenous Sets Industry Trends
11.4.2 Intravenous Sets Market Drivers
11.4.3 Intravenous Sets Market Challenges
11.4.4 Intravenous Sets Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intravenous Sets Distributors
12.3 Intravenous Sets Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
